Is This Experimental Drug the New Mounjaro? Why It's Too Early To Tell

Viking Therapeutics released results from a phase 2 clinical trial for its experimental weight loss drug. People who received weekly injections of the drug lost up to 14.7% of their body weight over 13 weeks, researchers found.
 
Daily News
 
 
Read on &#8594
 
 
 
'Reacher' Star Alan Ritchson Shares How He Manages Living with Bipolar Disorder
 
&#8594
 
Eating Ultra-Processed Foods Linked to 32 Health Issues Like Heart Disease
 
&#8594
 
CDC Tells Physicians to Conserve Tetanus Shots, Warns of Upcoming Shortage
 
&#8594
 
 
 
 
 
 
GET STARTED &#8594
 
 
 
 
Healthine
fb   tw   insta
 

No comments:

Post a Comment